Literature DB >> 12682218

Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT).

Fatima Martel1, Rosario Monteiro, Clara Lemos.   

Abstract

Serotonin plays important physiological functions at the intestinal level. However, nothing is known concerning its inactivation mechanisms in the human intestine. So, the aim of this work was to characterize the uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells. Uptake of [3H]serotonin at the apical membrane of Caco-2 cells was specific and Na+-, Cl--, and potential-dependent. It was concentration dependently inhibited by several monoamines (with the following rank order of potency: serotonin >> dopamine > or = noradrenaline) and tricyclic and nontricyclic antidepressants (with the following rank order of potency: fluoxetine > desipramine > cocaine > GBR 12909). In contrast, it was not affected by corticosterone (0.01-100 micro M) and was only partially inhibited by decynium-22 (0.001-10 micro M). Transepithelial apparent permeability (Papp) to [3H]serotonin in the apical-to-basolateral direction was reduced by desipramine (0.4 micro M) and fluoxetine (0.02 micro M), and it was not Na+-dependent nor affected by corticosterone (100 micro M). Uptake of [3H]serotonin at the basolateral membrane of Caco-2 cells was Na+-dependent and reduced by desipramine (0.4 micro M) and fluoxetine (0.02 micro M), and it was not affected by corticosterone (100 micro M). The Papp to [3H]serotonin in the basolateral-to-apical direction was reduced by desipramine (0.4 micro M) and fluoxetine (0.02 micro M), and it was not affected by Na+ omission or by corticosterone (100 micro M). Reverse transcriptase-polymerase chain reaction indicates that mRNA of the neuronal serotonin transporter (SERT) is present in Caco-2 cells and in human small intestine. In conclusion, these results suggest that human intestinal epithelial Caco-2 cells functionally express SERT, both at their apical and basolateral cell membranes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682218     DOI: 10.1124/jpet.103.049668

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

1.  Epidermal growth factor upregulates serotonin transporter in human intestinal epithelial cells via transcriptional mechanisms.

Authors:  Ravinder K Gill; Arivarasu Natarajan Anbazhagan; Ali Esmaili; Anoop Kumar; Saad Nazir; Jaleh Malakooti; Waddah A Alrefai; Seema Saksena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-27       Impact factor: 4.052

2.  Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.

Authors:  Manal A Elsheikh; Yosra S R Elnaggar; Dina Y Otify; Ossama Y Abdallah
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

3.  Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.

Authors:  Tianxiang Kevin Han; William R Proctor; Chester L Costales; Hao Cai; Ruth S Everett; Dhiren R Thakker
Journal:  J Pharmacol Exp Ther       Date:  2015-01-06       Impact factor: 4.030

4.  Methods to Study Epithelial Transport Protein Function and Expression in Native Intestine and Caco-2 Cells Grown in 3D.

Authors:  Arivarasu N Anabazhagan; Ishita Chatterjee; Shubha Priyamvada; Anoop Kumar; Sangeeta Tyagi; Seema Saksena; Waddah A Alrefai; Pradeep K Dudeja; Ravinder K Gill
Journal:  J Vis Exp       Date:  2017-03-16       Impact factor: 1.355

Review 5.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

6.  Luminal 5-HT stimulates colonic bicarbonate secretion in rats.

Authors:  I Kaji; Y Akiba; H Said; K Narimatsu; J D Kaunitz
Journal:  Br J Pharmacol       Date:  2015-08-26       Impact factor: 8.739

7.  Bioengineered in vitro enteric nervous system.

Authors:  Eleana Manousiouthakis; Ying Chen; Dana M Cairns; Rachel Pollard; Kaia Gerlovin; Michael J Dente; Yasmin Razavi; David L Kaplan
Journal:  J Tissue Eng Regen Med       Date:  2019-07-22       Impact factor: 3.963

8.  Novel promoter and alternate transcription start site of the human serotonin reuptake transporter in intestinal mucosa.

Authors:  D R Linden; S L White; E M Brooks; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2009-02-13       Impact factor: 3.598

9.  Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression.

Authors:  Ali Esmaili; Saad F Nazir; Alip Borthakur; Dan Yu; Jerrold R Turner; Seema Saksena; Amika Singla; Gail A Hecht; Waddah A Alrefai; Ravinder K Gill
Journal:  Gastroenterology       Date:  2009-09-10       Impact factor: 22.682

Review 10.  Serotonin pharmacology in the gastrointestinal tract: a review.

Authors:  D T Beattie; J A M Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.